Tumor engraftment was confirmed with bioluminescence imaging 24 h prior to treatment with F CAR-T cells, F CAR-T cells + systemic anti-PD-1 antibody or F i-CAR-T cells alone. Here, PDCD1 is linked to neoplasm.